Page last updated: 2024-08-21

alpha-aminopyridine and Viremia

alpha-aminopyridine has been researched along with Viremia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bai, F; Dang, BL; Kang, W; Kang, WZ; Li, JH; Liu, Q; Ma, J; Sun, YT; Wang, BW; Wang, CF; Wei, QQ; Yao, N; Zhao, K	1

Trials

1 trial(s) available for alpha-aminopyridine and Viremia

Article	Year
The histone deacetylase inhibitor chidamide induces intermittent viraemia in HIV-infected patients on suppressive antiretroviral therapy. HIV medicine, 2020, Volume: 21, Issue:11 Topics: Administration, Oral; Adult; Aminopyridines; Benzamides; Cell Line; Female; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Male; Middle Aged; RNA, Viral; Treatment Outcome; Viremia; Virus Latency	2020

Article

Year

The histone deacetylase inhibitor chidamide induces intermittent viraemia in HIV-infected patients on suppressive antiretroviral therapy.

HIV medicine, 2020, Volume: 21, Issue:11

Topics: Administration, Oral; Adult; Aminopyridines; Benzamides; Cell Line; Female; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Male; Middle Aged; RNA, Viral; Treatment Outcome; Viremia; Virus Latency

2020